Dr Murphy will be joining the management board and report to chief executive, Jack Bowles.
Based at BAT’s research and development hub in Southampton, Dr Murphy will be leading the global research and science team and ensure the implementation of best practices across all aspects of the company's work.
New Categories Products
Dr Murphy will help deliver further scientific evidence that supports BAT’s new category products. He has 20 years experience and has held a number of senior roles in research and development, operations and marketing at BAT.
Most recently, he served as executive vice president, US Scientific Research & Development, based at the headquarters of BAT’s US business in Winston-Salem, North Carolina.
Dr Murphy was product development lead for BAT’s first vapour launches in 2013–2014.
As head of reduced risk substantiation, he created and published the group’s nine-step scientific assessment framework to assess BAT’s new category products.
"James is a highly experienced, much-admired leader, with a proven track record of positively impacting our global scientific engagement with regulators, media and the external scientific community," said Jack Bowles, BAT chief executive.
"BAT has made significant progress over recent years to advance our commitment to tobacco harm reduction and deliver our purpose of building a better tomorrow. Jame's leadership and experience will help further accelerate that progress.”